MediGene medigene.de

Medigene is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases. Medigene is the first German biotech company to have revenues from a marketed product, Veregen, which is distributed by commercial partners companies. Medigene has two drug candidates in clinical trials, EndoTAG-1 and RhuDex, and is developing an innovat...Show all

Medigene is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases. Medi...Show all

See All Exits Recent Exits

Phone: +49-89-85 65-29 00

Fax:

Lochhamer Str. 11

Planegg-Martinsried, D-82152
Germany

MediGene - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2014-01-27Trianta ImmunotherapiesAcquired
See all 1 investments